Dr. Sivamurthy Kyathari, MD

Dr. Kyathari practices at Arizona Blood And Cancer Specialists Tucson - Paradise Falls in Tucson, Arizona.

Dr. Kyathari's NPI, 1124171533, was assigned on January 19, 2007. Dr. Kyathari holds Arizona license 58983.

Dr. Kyathari's primary practice is Arizona Blood and Cancer Specialists Tucson - Paradise Falls, at 3945 E Paradise Falls Dr Suite 105 Suite 105, Tucson, AZ 85712-6686. The practice phone is (520) 689-7022.

Dr. Kyathari's primary practice is Arizona Blood And Cancer Specialists Tucson - Paradise Falls in Tucson, Arizona. Dr. Kyathari is also affiliated with Tucson Medical Center. The medical group on file is Arizona Blood & Cancer Specialists. Dmand AI also links Dr. Kyathari to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kyathari practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kyathari's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kyathari is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kyathari's licenses on file in 3 states: Arizona, New York and West Virginia.

CMS data shows 64,431 Medicare services from Dr. Kyathari across 33 procedure codes in 2024, for 739 Medicare patients. Medicare paid $961,311 for them.

CMS counts 739 Medicare patients who saw Dr. Kyathari in 2024. The largest group is 75 to 84, with 362 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kyathari's median patient age at 75, with 56% women.

In 2024, Dr. Kyathari wrote 1,203 Medicare Part D claims for 247 patients. 76% of them were for generic drugs. CMS names the drug for 983 of them, across 25 drugs with 11 or more claims each, at $1,398,587 in total drug cost. In 2023, CMS named 1,189 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kyathari for performance year 2024, reported as part of a group. Dr. Kyathari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kyathari as offering telehealth.

CMS Open Payments shows 942 general payments to Dr. Kyathari from 76 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,062.